Nitin Gupta - Concepedia

Author

Nitin Gupta

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Gupta, Nitin, KhalidJ Farooqui, N Gupta, N. Gupta, Nealansh Embre Gupta, Nitin Gupta, Nitin K Gupta, Nitin K. Gupta, Nitin Kumar Gupta

Publications

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai University of California San Diego North Shore University Hospital New York University Cleveland Clinic

About

Nitin Gupta is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.1K
2	Health Sciences	3	3	399
3	Public Health	2	2	41
4	Allergy	2	2	54
5	Engineering	1	1	29

Nitin Gupta

Publications

Citations

H-Index

Page 1

	Year	Citations
Reprogramming of Intestinal Glucose Metabolism and Glycemic Control in Rats After Gastric Bypass Nima Saeidi, Luca Meoli, Eirini Nestoridi, Science Bariatric SurgerySleeve GastrectomyGastroenterologyPathologyGlucose Homeostasis	2013	328
Notum produced by Paneth cells attenuates regeneration of aged intestinal epithelium Nalle Pentinmikko, Sharif Iqbal, Miyeko Mana, Nature Developmental BiologyPaneth CellsAged Intestinal EpitheliumDigestive TractGut Barrier	2019	265
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium Neeraj Narula, Farhad Peerani, Joseph Meserve, The American Journal of Gastroenterology	2018	171
Impact of Obesity on Bowel Preparation for Colonoscopy Brian B. Borg, Nitin Gupta, Gary R. Zuckerman, Clinical Gastroenterology and Hepatology ObesityBody CompositionBowel PreparationGastroenterologyGi Technique	2009	155
Serum Analysis of Tryptophan Catabolism Pathway: Correlation With Crohnʼs Disease Activity Nitin Gupta, Ameet I. Thaker, Navya D. Kanuri, Inflammatory Bowel Diseases	2011	151
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases Joseph Meserve, Satimai Aniwan, Jenna L. Koliani‐Pace, Clinical Gastroenterology and Hepatology	2018	81
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele, Clinical Gastroenterology and Hepatology	2020	76
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, Inflammatory Bowel Diseases	2018	74
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis David M. Faleck, Adam C. Winters, Shreya Chablaney, Clinical Gastroenterology and Hepatology	2019	67
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies David T. Rubin, Jessica R. Allegretti, Julián Panés, The Lancet Placebo-controlled InductionGastroenterologyPathologyClinical GastroenterologyGastrointestinal Pathology	2024	62

Page 1